Vikram Juneja

Title: Vikram Juneja: Innovator in Immunotherapy

Introduction

Vikram Juneja is a prominent inventor based in Waltham, MA (US). He has made significant contributions to the field of immunotherapy, particularly through his innovative patents. With a total of 3 patents, Juneja is recognized for his work in developing T cell receptor constructs and their applications in treating diseases.

Latest Patents

Juneja's latest patents include groundbreaking advancements in immunotherapy. One of his notable patents is focused on T cell receptor constructs and their uses. This patent provides T cell receptors (TCRs) against peptide-MHC complexes, isolated nucleic acid molecules encoding TCRs, T cells expressing these receptors, and pharmaceutical compositions for disease treatment. Another significant patent involves neoantigens and their applications. This patent discloses immunotherapeutic compositions comprising immunotherapeutic peptides with neoepitopes, polynucleotides encoding these peptides, and antigen-presenting cells. The use of these immunotherapeutic compositions is also highlighted.

Career Highlights

Vikram Juneja has established himself as a key figure in the biotechnology sector. He is currently associated with BioNTech US Inc., where he continues to innovate and contribute to the advancement of immunotherapy. His work has the potential to impact the treatment of various diseases significantly.

Collaborations

Juneja collaborates with talented professionals in his field, including his coworker Jaewon Choi. Their combined expertise fosters an environment of innovation and progress in their research endeavors.

Conclusion

Vikram Juneja's contributions to immunotherapy through his patents and work at BioNTech US Inc. highlight his role as a leading inventor in the field. His innovative approaches to T cell receptors and neoantigens pave the way for future advancements in disease treatment.